2.63
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
16.24%
1.8089
|
2.1596 | 8.1557 | 2.6485 | 4.4568 |
| Operating Income/Loss |
16.24%
-1.8089
|
-2.1596 | -8.1557 | -2.6485 | -4.4568 |
| Net Income/Loss |
29.37%
-1.7949
|
-2.5411 | -8.1125 | -2.9751 | -5.2289 |
| Basic Average Shares |
959.92%
116.13
|
10.96 | - | 0.997 | 0.5749 |
| Diluted Average Shares |
959.92%
116.13
|
10.96 | - | 0.997 | 0.5749 |
| Basic Earnings Per Share |
91.30%
-0.02
|
-0.23 | - | -2.98 | -9.09 |
| Diluted Earnings Per Share |
91.30%
-0.02
|
-0.23 | - | -2.98 | -9.09 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):